Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: Warren Woessner
TALKING WRITTEN DESCRIPTION REQUIREMENT BLUES – ARIAD WOBBLES
On October 5, 2009, Ariad filed a 60 page brief (not counting attached appendices) with the Federal Circuit in support of its appeal in Ariad v. Lilly. (Attached below.) As you will recall from my post of August 24th, the … Continue reading
Director Kappos Kills Prosecution Regulations Package
Two years of fear and loathing have ended, as the USPTO has announced that it is rescinding the “Continuations” and “Claims” rules that have been hanging over the heads of practitioners, and will move to dismiss/vacate the pending lawsuit over … Continue reading
Posted in USPTO Practice and Policy
Tagged David Kappos, Dr. Tafas, Federal Circuit, Glaxo, USPTO, USPTO examiner, USPTO rules, Warren Woessner
1 Comment
Hal Wegner Wakes Up ACI Biotech Patents Forum in Boston
On Sept. 30th, Harold C. (Hal) Wegner gave a talk on current developments that emphasized the importance of inter partes reexamination, particularly as a weapon of patent destruction. His opinion, summarized by me, is that KSR is increasingly being applied … Continue reading
Posted in Post-Grant Issues
Tagged ACI, Federal Circuit, Harold Wegner, KSR, patent claims, Patent Law, Warren Woessner
Leave a comment
Guessing Right Is Not Sufficient — The Ghost Of Rasmusson Walks Among Us!
Rasmussen v. SmithKline Beecham Corp., 413 F.3d 1318 (Fed. Cir. 2005) (link below) was a truly scary decision that many of us practitioners hoped would be ignored by future Fed. Cir. panels as an aberration brought on by over-extensive prosecution, … Continue reading
Posted in Utility/How-To-Use
Tagged Federal Circuit, Janssen Pharmaceutica, patents, Rasmussen, Smithkline, Teva, Warren Woessner
Leave a comment